Literature DB >> 18499754

Organic anion transporter 1B1: an important factor in hepatic thyroid hormone and estrogen transport and metabolism.

Wendy M van der Deure1, Edith C H Friesema, Frank Jan de Jong, Yolanda B de Rijke, Frank H de Jong, André G Uitterlinden, Monique M B Breteler, Robin P Peeters, Theo J Visser.   

Abstract

Sulfation is an important pathway in the metabolism of thyroid hormone and estrogens. Sulfation of estrogens is reversible by estrogen sulfatase, but sulfation of thyroid hormone accelerates its degradation by the type 1 deiodinase in liver. Organic anion transporters (OATPs) are capable of transporting iodothyronine sulfates such as T4 sulfate (T4S), T3S, and rT3S or estrogen sulfates like estrone sulfate (E1S), but the major hepatic transporter for these conjugates has not been identified. A possible candidate is OATP1B1 because model substrates for this transporter include the bilirubin mimic bromosulfophthalein (BSP) and E1S, and it is highly and specifically expressed in liver. Therefore, OATP1B1-transfected COS1 cells were studied by analysis of BSP, E1S, and iodothyronine sulfate uptake and metabolism. Two Caucasian populations (155 blood donors and 1012 participants of the Rotterdam Scan Study) were genotyped for the OATP1B1-Val174Ala polymorphism and associated with bilirubin, E1S, and T4S levels. OATP1B1-transfected cells strongly induced uptake of BSP, E1S, T4S, T3S, and rT3S compared with mock-transfected cells. Metabolism of iodothyronine sulfates by cotransfected type 1 deiodinase was greatly augmented in the presence of OATP1B1. OATP1B1-Val174 showed a 40% higher induction of transport and metabolism of these substrates than OATP1B1-Ala174. Carriers of the OATP1B1-Ala174 allele had higher serum bilirubin, E1S, and T4S levels. In conclusion, OATP1B1 is an important factor in hepatic transport and metabolism of bilirubin, E1S, and iodothyronine sulfates. OATP1B1-Ala174 displays decreased transport activity and thereby gives rise to higher bilirubin, E1S, and T4S levels in carriers of this polymorphism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499754     DOI: 10.1210/en.2008-0169

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

Review 1.  Novel insights into thyroid hormones from the study of common genetic variation.

Authors:  Colin M Dayan; Vijay Panicker
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

2.  Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients.

Authors:  Guo-ping Yang; Hong Yuan; Bin Tang; Wei Zhang; Lian-sheng Wang; Zhi-jun Huang; Dong-sheng Ou-Yang; Gui-xiang Zhang; Hong-hao Zhou
Journal:  Acta Pharmacol Sin       Date:  2010-02-08       Impact factor: 6.150

3.  Genome-wide association meta-analysis for total thyroid hormone levels in Croatian population.

Authors:  Ivana Gunjača; Antonela Matana; Thibaud Boutin; Vesela Torlak; Ante Punda; Ozren Polašek; Vesna Boraska Perica; Caroline Hayward; Tatijana Zemunik; Maja Barbalić
Journal:  J Hum Genet       Date:  2019-03-01       Impact factor: 3.172

4.  Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis.

Authors:  Henriette E Meyer zu Schwabedissen; Joseph A Ware; David Finkelstein; Amarjit S Chaudhry; Sara Mansell; Matilde Leon-Ponte; Stephen C Strom; Hani Zaher; Ute I Schwarz; David J Freeman; Erin G Schuetz; Rommel G Tirona; Richard B Kim
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

5.  Catalysis leads to posttranslational inactivation of the type 1 deiodinase and alters its conformation.

Authors:  Bo Zhu; Ashutosh Shrivastava; Cristina Luongo; Ting Chen; John W Harney; Alessandro Marsili; Thuy-Van Tran; Anulika Bhadouria; Radhika Mopala; Amanda I Steen; P Reed Larsen; Ann Marie Zavacki
Journal:  J Endocrinol       Date:  2012-04-27       Impact factor: 4.286

6.  Several conserved positively charged amino acids in OATP1B1 are involved in binding or translocation of different substrates.

Authors:  Yi M Weaver; Bruno Hagenbuch
Journal:  J Membr Biol       Date:  2010-09-04       Impact factor: 1.843

7.  PharmGKB very important pharmacogene: SLCO1B1.

Authors:  Connie Oshiro; Lara Mangravite; Teri Klein; Russ Altman
Journal:  Pharmacogenet Genomics       Date:  2010-03       Impact factor: 2.089

8.  Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir.

Authors:  Emanuele Focà; Andrea Calcagno; Andrea Bonito; Jessica Cusato; Elisabetta Domenighini; Antonio D'Avolio; Eugenia Quiros Roldan; Laura Trentini; Filippo Castelnuovo; Giovanni Di Perri; Francesco Castelli; Stefano Bonora
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 9.  The SLCO (former SLC21) superfamily of transporters.

Authors:  Bruno Hagenbuch; Bruno Stieger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 10.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.